Efficacy of ifosfamide and doxorubicin given as a phase II "window" in children with newly diagnosed metastatic rhabdomyosarcoma: A report from the intergroup rhabdomyosarcoma study group

E. Sandler, E. Lyden, F. Ruymann, H. Maurer, M. Wharam, D. Parham, M. Link, W. Crist

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Efficacy of ifosfamide and doxorubicin given as a phase II "window" in children with newly diagnosed metastatic rhabdomyosarcoma: A report from the intergroup rhabdomyosarcoma study group'. Together they form a unique fingerprint.

Medicine & Life Sciences